Table 2.
Risk factors associated with cardiac hypertrophy in the cohort study.
| Variable | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| OR (95% CI) | p value | OR (95% CI) | p value | |
| Age (years) | 1.013 (1.005-1.022) | 0.002 | 1.002 (0.992-1.012) | 0.678 |
| Male sex | 0.665 (0.555-0.798) | <0.001 | 0.649 (0.518-0.813) | <0.001 |
| Smoke | 0.753 (0.620-0.915) | 0.004 | 0.944 (0.746-1.195) | 0.634 |
| Drink | 0.855 (0.683-1.070) | 0.170 | ||
| SBP (mmHg) | 1.013 (1.009-1.018) | <0.001 | 1.011 (1.006-1.016) | <0.001 |
| DBP (mmHg) | 1.011 (1.004-1.018) | 0.001 | 1.004 (0.996-1.012) | 0.294 |
| Pulse (beats/min) | 0.999 (0.993-1.005) | 0.757 | ||
| Medical history | ||||
| T2DM | 1.574 (1.310-1.892) | <0.001 | 1.458 (1.194-1.780) | <0.001 |
| AF | 1.145 (0.917-1.430) | 0.232 | ||
| CAD | 1.245 (1.029-1.507) | 0.024 | 1.128 (0.918-1.387) | 0.251 |
| CHF | 1.436 (1.062-1.943) | 0.019 | 0.837 (0.600-1.169) | 0.297 |
| Laboratory data | ||||
| eGFR < 90 (mL/(min•1.73 m2)) | 1.276 (1.068-1.523) | 0.007 | 1.049 (0.855-1.286) | 0.649 |
| Dyslipidemia | 1.246 (1.043-1.487) | 0.015 | 1.250 (1.032-1.514) | 0.022 |
| HHcy | 1.268 (1.062-1.514) | 0.009 | 1.293 (1.049-1.594) | 0.016 |
| Echocardiographic parameters | ||||
| LAE | 2.785 (2.292-3.385) | <0.001 | 2.663 (2.158-3.286) | <0.001 |
| LVEDD, mm | 1.010 (0.993-1.026) | 0.251 | ||
| LVEF < 40% | 1.054 (0.634-1.751) | 0.840 | ||
| Medication | ||||
| Antihypertensive use | 1.561 (1.127-2.161) | 0.007 | 1.197 (0.851-1.685) | 0.302 |
Abbreviations as in Table 1.